Low-dose cytosine arabinoside as remission induction therapy in refractory adult acute lymphocytic leukemia.
Onundarson
P T
PT
University of Rochester Medical Center, Rochester, New York 14642.
Rowe
J M
JM
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D009364:Neoplasm Recurrence, Local; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D012074:Remission Induction
D003561:Cytarabine